IAS 2015
NAM is the official provider of online scientific reporting for the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), taking place in Vancouver, Canada, 19th-22nd July 2015.
-
19-22 July 2015
Implant and injectable hormonal contraception most effective methods for women living with HIV
Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection
Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health
Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy
PrEP demo project finds the people at highest HIV risk generally take PrEP most consistently
Vancouver's treatment as prevention success is also due to harm reduction and addiction treatment
HIV self-testing may help the 'hard to reach' learn their status, but uncertainties remain
Peer-led network intervention substantially lowers HIV infections in people who use drugs in Ukraine
Gay youth PrEP study finds good retention and reasonable adherence
Giving people information about HIV treatment as prevention lessens stigma and increases testing rates
New NNRTI doravirine suppresses HIV as well as efavirenz but with fewer central nervous system side-effects
Same-day start to antiretroviral treatment leads to faster HIV suppression in San Francisco
Opioid substitution therapy combined with HIV treatment saves the lives of more drug users than ART alone
Younger gay men have much lower risk of acquiring HIV than previous generations, but racial disparities persist
Half of African migrants diagnosed with HIV in France acquired HIV while living there
Next-generation maturation inhibitor BMS-955176 shows good antiviral activity in combination with atazanavir
Intermittent PrEP may be a robust strategy for anal sex – vaginal much less certain
'Nuanced' sero-adaptive behaviours being used by Australian and American gay men